LONDON, Dec 20 (Reuters) - GlaxoSmithKline on Monday
named former Tesco CEO Dave Lewis as non-executive
chair designate of the new Consumer Healthcare company which
will result from the proposed demerger from GSK in 2022.
It said Lewis' appointment will take effect from Jan. 1
2022.
(Reporting by James Davey; editing by Guy Faulconbridge)